CSIMarket Company Name, Ticker, Industry, else..
 
Genelux Corporation  (NASDAQ: GNLX)
 
Price: $2.4750 $0.13 5.769%
Day's High: $2.494999885559082 Week Perf: -0.6 %
Day's Low: $ 2.36 30 Day Perf: -4.81 %
Volume (M): 134,863 52 Wk High: $ 8.53
Volume (M$): $ 0 52 Wk Avg: $3.49
Open: $2.36 52 Wk Low: $2.29



 Market Capitalization (Millions $) 111
 Shares Outstanding (Millions) 45
 Employees 26
 Revenues (TTM) (Millions $) -
 Net Income (TTM) (Millions $) -36
 Cash Flow (TTM) (Millions $) 3
 Capital Exp. (TTM) (Millions $) 3

Business Description


Genelux Corporation is a biotechnology company specializing in the development of advanced oncolytic viruses for the treatment of cancer. The company utilizes its proprietary platform technology to create customized viruses that selectively target and destroy cancer cells while leaving healthy cells unharmed. These oncolytic viruses are designed to replicate within tumor cells, causing them to burst and release antigens that stimulate the immune system to mount an anti-tumor response. Genelux's approach has shown promising results in preclinical studies and is currently being evaluated in clinical trials. The company's ultimate goal is to provide a safe and effective alternative or complement to traditional cancer therapies.


   Company Address: 2625 Townsgate Road Westlake Village 91361 CA
   Company Phone Number: 267-9889   Stock Exchange / Ticker: NASDAQ GNLX


   

Stock Performances by Major Competitors

5 Days Decrease / Increase
     
BMY   -0.6%    
JNJ        0.86% 
LLY        2.01% 
MRK        1.52% 
REGN   -1.32%    
TEVA        8.2% 
• View Complete Report
   



Shares

Genelux Corporation’s $10.5 Million Offering: Strategic Resilience Amid Market Challenges,

Published Tue, Mar 25 2025 12:31 PM UTC

Genelux Corporation Secures $10.5 Million Through Underwritten Offering Amid Market Volatility, Showcases Strategic ResilienceOn March 25, 2025, Genelux Corporation (Nasdaq: GNLX), a late clinical-stage immuno-oncology company based in Westlake Village, California, announced the pricing of an underwritten offering that is set to bolster its financial position in a challengi...
Stocks on the Move

Genelux Corp A Strategic Shift Reinforces Optimism Amidst Market Volatility

Published Mon, Jun 24 2024 7:16 PM UTC

The Genelux Corporation has been making waves in the market recently, with several significant developments that are worth paying attention to. In this article, we will outline the facts surrounding these events and assess their impact on the company s performance. Despite trailing the overall market in recent months, Genelux Corporation s strategic moves indicate a promisin...
Shares

Genelux Corporation grants inducement awards to new employees, signaling expansion and advancement in immuno-oncology sector

Published Thu, Sep 14 2023 11:00 AM UTC



WESTLAKE VILLAGE, Calif., Sept. 14, 2023 - Genelux Corporation (NASDAQ: GNLX), a late clinical-stage immuno-oncology company, has recently made a significant announcement regarding the granting of inducement awards to seven new employees. This move by the company s Board of Directors represents a strategic step towards bolstering its workforce and fostering further...



Fundamental Analysis

Valuation Current
Price to Earnings PE Ratio (TTM) -
Price to Earnings PE Ratio (Expected) -
Price to Sales (TTM) 13,909.32
Price to Sales (Expected) -
Price to Book 6.91
PEG (TTM) -

Financial Strength Current
Quick Ratio 2.05
Working Capital Ratio 2.08
Leverage Ratio (MRQ) 1.04
Total Debt to Equity -
Interest Coverage (TTM) -
Debt Coverage (TTM) -

Per Share Current
Earnings (TTM) -0.87 $
Revenues (TTM) 0 $
Cash Flow (TTM) 0.06 $
Cash 0.66 $
Book Value 0.36 $
Dividend (TTM) 0 $

Efficiency Current
Revenue per Employee (TTM) -
Net Income per Employee (TTM) -1,369,077
Receivable Turnover Ratio (TTM) -
Inventory Turnover Ratio (TTM) -
Asset Turnover Ratio (TTM) -

Profitability Ratios Current
Gross Margin (MRQ) -
Operating Margin (MRQ) -
Net Margin (MRQ) -
Net Cash Flow Margin (MRQ) -
Effective Tax Rate (TTM) -

Management Effectiveness Current
Return On Assets (TTM) -
Return On Investment (TTM) -
Return On Equity (TTM) -
Dividend Yield -
Pay out Ratio (TTM) -






Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.